The pathophysiology of Inflammatory Bowel Disease (IBD), a clinical entity with significant morbidity and mortality, is not completely understood. Emerging evidence indicates that neuropeptides are major participants in the pathogenesis of colonic inflammation. We showed that the neuropeptide neurotensin (NT) acts as a proinflammatory mediator in the acute phase of colitis. Our preliminary evidence also indicates that NT deficient mice have reduced intestinal inflammatory responses, providing direct evidence for the importance of this peptide in intestinal inflammation. However, NT also promotes healing during the repair phase of inflammation by activating the EGF receptor (EGFR) and phosphorylating the anti-apoptotic signaling molecule Akt. Thus, our hypothesis for aim 1 of this revised renewal application is that NT participates in the healing phase of colitis by reducing apoptosis and increasing cell proliferation.
Aim 1 therefore will examine the signaling mechanisms involved in NT-NT receptor 1 (NTR1)-induced Akt-and EGFR-related anti-apoptotic and proliferative responses in isolated colonocytes and models of experimental colitis. We also found increased NT and NTR1 expression in the mesenteric fat depots during colitis and identified expression of NT and NTR1 in mouse preadipocytes that respond to NT be release of cytokines and increased proliferation. These findings link for the first time NT-NTR1-dependent inflammatory changes in mesenteric fat during colitis and may be of major importance in IBD where fat wrapping of the bowel is a common finding during surgery of IBD patients. Thus, in aim 2 will examine the NT-mediated cross talk between the colonic mucosa and mesenteric depots in acute and chronic experimental colitis by comparing NT and NTR1 expression in mesenteric fat to the degree of mucosal and adipose tissue inflammation in IBD-related models. Experiments in isolated preadipocytes will examine the mechanisms by which NT stimulates release of proinflammatory cytokines and adipokines, alters expression of adhesion molecules, and stimulates macrophage migration to these cells. Experiments in aim 1 and 2 will also compare colitis and inflammatory changes in fat depots between NT deficient and wild type mice. Studies in aim 3 will determine the signal transduction pathways involved in NT-induced IGF-1R phosphorylation in preadipocytes and examine the mechanisms by which NT-NTR1 interactions lead to cell proliferation and migration. Our results will provide important insights on the role of NT and its receptor in colonic inflammation and its expanded role in activation and inflammation of mesenteric adipose tissue observed in IBD and animal models of experimental colitis. PUBLIC HEALTH REVELVANCE This project will examine the pathophysiologic mechanisms by which the neuropeptide neurotensin participates in the pathogenesis of intestinal inflammation and Inflammatory Bowel Disease. Part of this project also examines how this neuropeptide influences development of inflammation in the adjacent fat tissue following colonic inflammatory changes.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Research Project (R01)
Project #
Application #
Study Section
Gastrointestinal Mucosal Pathobiology Study Section (GMPB)
Program Officer
Hamilton, Frank A
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California Los Angeles
Internal Medicine/Medicine
Schools of Medicine
Los Angeles
United States
Zip Code
Jara, Adam; Benner, Chance M; Sim, Don et al. (2014) Elevated systolic blood pressure in male GH transgenic mice is age dependent. Endocrinology 155:975-86
Tchkonia, Tamara; Thomou, Thomas; Zhu, Yi et al. (2013) Mechanisms and metabolic implications of regional differences among fat depots. Cell Metab 17:644-56
Koukos, Georgios; Polytarchou, Christos; Kaplan, Jess L et al. (2013) MicroRNA-124 regulates STAT3 expression and is down-regulated in colon tissues of pediatric patients with ulcerative colitis. Gastroenterology 145:842-52.e2
Tuominen, Iina; Al-Rabadi, Leina; Stavrakis, Dimitris et al. (2013) Diet-induced obesity promotes colon tumor development in azoxymethane-treated mice. PLoS One 8:e60939
Bugni, James M; Rabadi, Leina Al-; Jubbal, Kevin et al. (2012) The neurotensin receptor-1 promotes tumor development in a sporadic but not an inflammation-associated mouse model of colon cancer. Int J Cancer 130:1798-805
Law, Ivy Ka Man; Murphy, Jane E; Bakirtzi, Kyriaki et al. (2012) Neurotensin-induced proinflammatory signaling in human colonocytes is regulated by ýý-arrestins and endothelin-converting enzyme-1-dependent endocytosis and resensitization of neurotensin receptor 1. J Biol Chem 287:15066-75
Bakirtzi, Kyriaki; Hatziapostolou, Maria; Karagiannides, Iordanes et al. (2011) Neurotensin signaling activates microRNAs-21 and -155 and Akt, promotes tumor growth in mice, and is increased in human colon tumors. Gastroenterology 141:1749-61.e1
Zhao, Dezheng; Bakirtzi, Kyriaki; Zhan, Yanai et al. (2011) Insulin-like growth factor-1 receptor transactivation modulates the inflammatory and proliferative responses of neurotensin in human colonic epithelial cells. J Biol Chem 286:6092-9
Rhee, Sang H; Pothoulakis, Charalabos; Mayer, Emeran A (2009) Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol 6:306-14
Koon, Hon-Wai; Kim, You Sun; Xu, Hua et al. (2009) Neurotensin induces IL-6 secretion in mouse preadipocytes and adipose tissues during 2,4,6,-trinitrobenzensulphonic acid-induced colitis. Proc Natl Acad Sci U S A 106:8766-71

Showing the most recent 10 out of 19 publications